IMMH 010 maleate

Request For Quotation
IMMH 010 maleate Suppliers list
Company Name: TargetMol Chemicals Inc.  
Tel: +1-781-999-5354; +1-00000000000
Email: marketing@targetmol.com
Company Name: Beijing Jin Ming Biotechnology Co., Ltd.  
Tel: 010-60605840
Email: psaitong@jm-bio.com
Company Name: Nantong QuanYi Biotechnology Co., Ltd  
Tel: 0513-66337626 18051384581
Email: sales@chemhifuture.com
Company Name: Shanghai Yifei Biotechnology Co. , Ltd.  
Tel: 021-65675885 18964387627
Email: customer_service@efebio.com
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn

IMMH 010 maleate manufacturers

  • IMMH 010 maleate
  • IMMH 010 maleate pictures
  • $195.00
  • 2026-07-15
  • CAS:2541982-47-0
  • Purity: 99.85%
  • Supply Ability: 10g
IMMH 010 maleate Basic information
Product Name:IMMH 010 maleate
Synonyms:IMMH 010 maleate;YPD-30 maleate
CAS:2541982-47-0
MF:C32H32BrClN2O5.C4H4O4
MW:756.04
EINECS:
Product Categories:
Mol File:2541982-47-0.mol
IMMH 010 maleate Structure
IMMH 010 maleate Chemical Properties
Safety Information
MSDS Information
IMMH 010 maleate Usage And Synthesis
UsesIMMH-010 maleate is a prodrug that serves as a novel PD-L1 inhibitor, exhibiting potential antitumor activity for the treatment of neurological disorders and advanced malignant solid tumors. IMMH-010 maleate is rapidly converted to its active form, YPD-29B, following oral administration. IMMH-010 maleate is poised for advancing research in the field of PD-L1 inhibitors and related therapeutic applications.
References[1] Simultaneous Determination of a Novel PD-L1 Inhibitor, IMMH-010, and Its Active Metabolite, YPD-29B, in Rat Biological Matrices by Polarity-Switching Liquid Chromatography-Tandem Mass Spectrometry: Application to ADME Studies
IMMH 010 maleate Preparation Products And Raw materials
Tag:IMMH 010 maleate(2541982-47-0) Related Product Information
Ivonescimab Pembrolizumab Toripalimab Research Grade Visugromab (DHJ48302) Camrelizumab Tislelizumab